Efficacy of Penile Extenders

Indications and Level of Evidence

• The European Association of Urology recommends penile extender therapy as an adjunct treatment, showing average length increases of 1 cm 1
• Penile extender therapy combined with collagenase or other conservative treatments improves outcomes compared to monotherapy 1
• The use of penile extenders after Peyronie's disease surgery helps prevent length loss 1

Efficacy Data

• The European Urology guidelines indicate that penile extender therapy requires prolonged use of 2-8 hours a day, appears safe with no serious adverse events reported, and shows average length increases of 1 cm as an adjunct therapy 1

Treatment Protocol

• The European Urology guidelines suggest that penile extender therapy works better in combination with inhibitors PDE5 (tadalafil 5 mg daily) and collagenase of Clostridium histolyticum (CCH) for curvatures 30-90 degrees 1

Comparison with Other Therapeutic Options

• Penile extender therapy is favored over vacuum devices for improving curvature and erectile function in Peyronie's disease 1
• Vacuum devices show initial efficacy of 90% for erectile dysfunction, but decrease to 50-64% after 2 years 1

Safety Profile

• No serious adverse events have been reported with penile extender therapy, with only transient and mild adverse events (temporary redness, mild discomfort) 1
• The therapy has excellent overall tolerability 1

Clinical Caveats

• Realistic expectations are essential, with modest but clinically significant improvements (1-1.5 cm in length, 11-17 degrees in curvature) 1
• Adherence to daily use for at least 3 months is critical for efficacy 1
• Surgery should be considered if there is no response to conservative therapy after 3-6 months, curvature is greater than 60 degrees with complex deformities, or severe erectile dysfunction is present 1